March 25 - 28, 2012
Vancouver, BC, Canada
See Programme (349 KB)
More information available on: http://ti.ubc.ca/ISDB-2012
Category: Campaigns
Pharmacovigilance in Europe. Signal detection left to pharmaceutical companies: danger!
Answer to the consultation on the "Concept paper on pharmacovigilance implementing measures"
read (292 KB)
Revised proposals on “information” to patients: still an open door to advertising of prescription-only medicines
Direct-to-consumer "information" on prescription medicines by manufacturers exposes citizens to misleading messages, puts public health at risk and threatens Member State's social protection systems.
read (180 KB)